These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 32735190)
1. A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018. Ansari B; Tote KM; Rosenberg ES; Martin EG Public Health Rep; 2020; 135(1_suppl):100S-127S. PubMed ID: 32735190 [TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018. Lee B; Zhao W; Yang KC; Ahn YY; Perry BL JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816 [TBL] [Abstract][Full Text] [Related]
3. The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review. Mauri AI; Townsend TN; Haffajee RL Milbank Q; 2020 Mar; 98(1):57-105. PubMed ID: 31800142 [TBL] [Abstract][Full Text] [Related]
4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids. Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331 [TBL] [Abstract][Full Text] [Related]
6. The opioid crisis: Origins, trends, policies, and the roles of pharmacists. Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827 [TBL] [Abstract][Full Text] [Related]
7. The US Opioid Crisis: Current Federal and State Legal Issues. Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113 [TBL] [Abstract][Full Text] [Related]
8. Evidence for state, community and systems-level prevention strategies to address the opioid crisis. Haegerich TM; Jones CM; Cote PO; Robinson A; Ross L Drug Alcohol Depend; 2019 Nov; 204():107563. PubMed ID: 31585357 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review. Beaudoin FL; Banerjee GN; Mello MJ J Opioid Manag; 2016; 12(2):109-18. PubMed ID: 27194195 [TBL] [Abstract][Full Text] [Related]
11. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada. Strike C; Watson TM Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595 [TBL] [Abstract][Full Text] [Related]
13. The use of cannabis in response to the opioid crisis: A review of the literature. Vyas MB; LeBaron VT; Gilson AM Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073 [TBL] [Abstract][Full Text] [Related]
14. Provider perceptions of system-level opioid prescribing and addiction treatment policies. Haffajee RL; French CA Curr Opin Psychol; 2019 Dec; 30():65-73. PubMed ID: 30856591 [TBL] [Abstract][Full Text] [Related]
15. In our war against the opioid epidemic, could 'weed' be a winner? Ding DD; Balkrishnan R; Diaby V Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):423-429. PubMed ID: 32799573 [TBL] [Abstract][Full Text] [Related]
16. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone. Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501 [TBL] [Abstract][Full Text] [Related]
17. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732 [TBL] [Abstract][Full Text] [Related]
18. The effects of state rules on opioid prescribing in Indiana. Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984 [TBL] [Abstract][Full Text] [Related]
19. The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons. Liang D; Shi Y Drug Alcohol Depend; 2020 Jan; 206():107754. PubMed ID: 31786399 [TBL] [Abstract][Full Text] [Related]